286 related articles for article (PubMed ID: 32376796)
41. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
42. Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?
Nishimura Y; Nishikori A; Sawada H; Czech T; Otsuka Y; Nishimura MF; Mizuno H; Sawa N; Momose S; Ohsawa K; Otsuka F; Sato Y
J Clin Exp Hematop; 2022 Jun; 62(2):99-105. PubMed ID: 35249898
[TBL] [Abstract][Full Text] [Related]
43. Candidate biomarkers for idiopathic multicentric Castleman disease.
Sumiyoshi R; Koga T; Kawakami A
J Clin Exp Hematop; 2022; 62(2):85-90. PubMed ID: 35768241
[TBL] [Abstract][Full Text] [Related]
44. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
[TBL] [Abstract][Full Text] [Related]
45. [Recent advances in diagnosis and treatment of idiopathic multicentric Castleman disease].
Okamoto S
Rinsho Ketsueki; 2019; 60(9):1205-1211. PubMed ID: 31597845
[TBL] [Abstract][Full Text] [Related]
46. Treatment-resistant idiopathic multicentric Castleman disease with thrombocytopenia, anasarca, fever, reticulin fibrosis, renal dysfunction, and organomegaly managed with Janus kinase inhibitors: A case report.
Kakutani T; Nunokawa T; Chinen N; Tamai Y
Medicine (Baltimore); 2022 Dec; 101(48):e32200. PubMed ID: 36482523
[TBL] [Abstract][Full Text] [Related]
47. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
48. Glycogen synthase kinase 3β/CCR6-positive bone marrow cells correlate with disease activity in multicentric Castleman disease-TAFRO.
Abe N; Kono M; Kono M; Ohnishi N; Sato T; Tarumi M; Yoshimura M; Sato T; Karino K; Shimizu Y; Fujieda Y; Kato M; Hasebe R; Oku K; Murakami M; Atsumi T
Br J Haematol; 2022 Mar; 196(5):1194-1204. PubMed ID: 34873687
[TBL] [Abstract][Full Text] [Related]
49. Longitudinal, natural history study reveals the disease burden of idiopathic multicentric Castleman disease.
Bustamante MS; Pierson SK; Ren Y; Bagg A; Brandstadter JD; Srkalovic G; Mango N; Alapat D; Lechowicz MJ; Li H; Van Rhee F; Lim MS; Fajgenbaum DC
Haematologica; 2024 Jan; ():. PubMed ID: 38205523
[TBL] [Abstract][Full Text] [Related]
50. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
[TBL] [Abstract][Full Text] [Related]
51. Successful treatment with tacrolimus in TAFRO syndrome: two case reports and literature review.
Shirai T; Onishi A; Waki D; Saegusa J; Morinobu A
Medicine (Baltimore); 2018 Jun; 97(23):e11045. PubMed ID: 29879072
[TBL] [Abstract][Full Text] [Related]
52. Renal histology in a patient with TAFRO syndrome: a case report.
Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
[TBL] [Abstract][Full Text] [Related]
53. Epstein-Barr Virus-Positive Cutaneous and Systemic Plasmacytosis with TAFRO Syndrome-like Symptoms Successfully Treated with Rituximab.
Kakiuchi S; Akiyama H; Harima I; Takagi I; Rikitake J; Kozuki Y; Inaba M; Fujiwara H; Kurose N; Yamada S; Masaki Y
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837418
[TBL] [Abstract][Full Text] [Related]
54. Fatal case of TAFRO syndrome with unilateral adrenal hemorrhage in early-stage disease.
Okamoto T; Ochi S; Motokawa Y; Azumi H; Kobayashi S; Nakamura F; Nakatani T; Yagi H
J Clin Exp Hematop; 2021; 61(2):109-113. PubMed ID: 34092711
[TBL] [Abstract][Full Text] [Related]
55. The disease course of Castleman disease patients with fatal outcomes in the ACCELERATE registry.
Fajgenbaum DC; Pierson SK; Kanhai K; Bagg A; Alapat D; Lim MS; Lechowicz MJ; Srkalovic G; Uldrick TS; van Rhee F;
Br J Haematol; 2022 Jul; 198(2):307-316. PubMed ID: 35507638
[TBL] [Abstract][Full Text] [Related]
56. Intracranial Hemorrhage in a Patient with TAFRO Syndrome Treated with Cyclosporine A and Rituximab.
Akagi Y; Kato T; Yamashita Y; Hosoi H; Murata S; Yamamoto S; Warigaya K; Nakao T; Murata S; Sonoki T; Tamura S
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577894
[TBL] [Abstract][Full Text] [Related]
57. TAFRO Syndrome: Guidance for Managing Patients Presenting Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly.
Miura K; Nishimaki-Watanabe H; Takahashi H; Nakagawa M; Otake S; Hamada T; Koike T; Iizuka K; Takeuchi Y; Kurihara K; Endo T; Ito S; Nukariya H; Namiki T; Hayashi Y; Nakamura H
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927484
[TBL] [Abstract][Full Text] [Related]
58. [A case report of TAFRO syndrome].
Zhou GP; Zhou QY; Zhu JH
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):814-817. PubMed ID: 34393252
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.
Nishikori A; Nishimura MF; Fajgenbaum DC; Nishimura Y; Maehama K; Haratake T; Tabata T; Kawano M; Nakamura N; Momose S; Sumiyoshi R; Koga T; Yamamoto H; van Rhee F; Kawakami A; Sato Y
J Clin Pathol; 2024 Feb; ():. PubMed ID: 38378248
[TBL] [Abstract][Full Text] [Related]
60. Radiological Imaging Findings of Adrenal Abnormalities in TAFRO Syndrome: A Systematic Review.
Kurokawa R; Baba A; Kano R; Kaneko Y; Kurokawa M; Gonoi W; Abe O
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
